Martin Puhr

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Radical Prostatectomy

Editorial Comment

Cell Proliferation

Extracellular Matrix

Top Venues

Prostate cancer and prostatic diseases

International journal of molecular sciences

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, Jana Scholze, Jörg Hofmann, Pia Hönscheid, Gustavo B Baretton, Kevin Woods, Borhane Guezguez, Anna Dubrovska, Sascha D Markowitsch, Christian Thomas, Martin Puhr, Holger Hans Hermann Erb
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer. Oncogene 43 (26) (2024)
Alicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, Jana Scholze, Jörg Hofmann, Pia Hönscheid, Gustavo B Baretton, Kevin Woods, Borhane Guezguez, Anna Dubrovska, Sascha D Markowitsch, Christian Thomas, Martin Puhr, Holger Hans Hermann Erb
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer. Oncogene 43 (26) (2024)
Alicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, Jana Scholze, Jörg Hofmann, Pia Hönscheid, Gustavo B Baretton, Kevin Woods, Borhane Guezguez, Anna Dubrovska, Sascha D Markowitsch, Christian Thomas, Martin Puhr, Holger Hans Hermann Erb
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer. Oncogene (2024)
Alicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, Jana Scholze, Jörg Hofmann, Pia Hönscheid, Gustavo B Baretton, Kevin Woods, Borhane Guezguez, Anna Dubrovska, Sascha D Markowitsch, Christian Thomas, Martin Puhr, Holger Hans Hermann Erb
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer. Oncogene 43 (26) (2024)
Pia V Hönscheid, Gustavo B Baretton, Martin Puhr, Tiziana Siciliano, Justus S Israel, Matthias B Stope, Celina Ebersbach, Alicia-Marie K Beier, Christian Thomas, Holger Hans Hermann Erb
Prostate Cancer's Silent Partners: Fibroblasts and Their Influence on Glutamine Metabolism Manipulation. International journal of molecular sciences 25 (17) (2024)
Anita Csizmarik, Nikolett Nagy, Dávid Keresztes, Melinda Váradi, Thilo Bracht, Barbara Sitek, Kathrin E Witzke, Martin Puhr, Ilona Tornyi, József Lázár, László Takács, Gero Kramer, Sabina Sevcenco, Agnieszka Maj-Hes, Boris Hadaschik, Péter Nyirády, Tibor Szarvas
Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2023)
Andrea Eigentler, Florian Handle, Silvia Schanung, Antonia Degen, Hubert Hackl, Holger H H Erb, Georgios Fotakis, Julia Hoefer, Christian Ploner, Karin Jöhrer, Isabel Heidegger, Andreas Pircher, Werner Klotz, Manfred Herold, Georg Schäfer, Zoran Culig, Martin Puhr
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts. Oncogene (2023)
Martin Puhr, Andrea Eigentler, Florian Handle, Hubert Hackl, Christian Ploner, Isabel Heidegger, Georg Schaefer, Maximilian P Brandt, Julia Hoefer, Gabri Van der Pluijm, Helmut Klocker
Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer. Oncogene 40 (17) (2021)
Stanislav Drápela, Prashant Khirsariya, Thomas A Kirkland, Radek Fedr, Tereza Suchánková, Diana Búzová, Jan Cerveny, Aleš Hampl, Martin Puhr, William R Watson, Zoran Culig, Lumír Krejčí, Kamil Paruch, Karel Souček
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe. Molecular oncology 14 (10) (2020)